Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Particulate & foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables.

867 FDA drug recalls with this cause, newest first.

These recalls involve visible foreign material - glass, metal, fibers, rubber or other debris - most often found in injectable or liquid products, where nothing besides the intended ingredients should be present. It also includes foreign tablets or capsules found in a bottle of a different product. In an injectable a stray particle can go straight into the bloodstream, which is why a noticeable share of these recalls are Class I.

Class II · Moderate risk

Lidocaine HCL 1%

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Ongoing Particulate / foreign matter Denver Solutions, LLC DBA Leiters Health NDC 71449-090-42 D-0363-2024
Class II · Moderate risk

Moxifloxacin 5mg/ml

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Ongoing Particulate / foreign matter Denver Solutions, LLC DBA Leiters Health NDC 71449-097-42 D-0362-2024
Class II · Moderate risk

Moxifloxacin PF

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Ongoing Particulate / foreign matter Denver Solutions, LLC DBA Leiters Health NDC 71449-096-42 D-0361-2024
Class II · Moderate risk

Tizanidine Tablets

Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

Completed Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 55111-180-15 D-0223-2024
Class II · Moderate risk

Tacrolimus Capsules

Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.

Terminated Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 55111-526-01 D-0219-2024
Class III · Low risk

Lisinopril Tablets USP 20 mg

Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

Terminated Particulate / foreign matter NCS Healthcare of Kentucky Inc NDC 0615-7718-05 D-0114-2024